Genetic Cancer Test Granted FDA Breakthrough Device Designation
The designation’s accelerated regulatory review is intended to expedite use of the diagnostic in pharmaceutical trials.
Read MorePosted by Chaunie Brusie | Jun 30, 2019 | Breast, Lung Cancer |
The designation’s accelerated regulatory review is intended to expedite use of the diagnostic in pharmaceutical trials.
Read MorePosted by Chaunie Brusie | Jun 27, 2019 | Cancer |
A companion diagnostic from Caris Life Sciences is the first test to detect gene fusions across all solid tumors.
Read MorePosted by Chaunie Brusie | Jun 21, 2019 | Microarray Systems, Software |
The multiplexed assay can positively characterize and differentiate a wide variety of influenza A virus strains as seasonal or nonseasonal, with same-day results.
Read MorePosted by Chaunie Brusie | Jun 20, 2019 | Research, Storage |
Partnering universities and companies in Europe and the United States have developed a hybrid Cloud-based platform for fast and cost-efficient whole-genome sequencing and analysis.
Read MorePosted by Chaunie Brusie | Jun 20, 2019 | Breast |
The iGAP registry will capture information regarding breast cancer risk assessment, genetic testing utilization, and the impact of genetic information on treatment practices and patient outcomes.
Read More